Vaxart, Inc.
VXRT
$0.3181
-$0.0258-7.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -66.95M | -72.34M | -75.66M | -81.74M | -82.47M |
| Total Depreciation and Amortization | 8.85M | 8.95M | 8.79M | 8.74M | 8.62M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.07M | 11.14M | 12.15M | 13.40M | 14.24M |
| Change in Net Operating Assets | 3.26M | 1.31M | -7.01M | -7.58M | -10.85M |
| Cash from Operations | -44.76M | -50.94M | -61.74M | -67.18M | -70.45M |
| Capital Expenditure | -554.00K | -406.00K | -679.00K | -763.00K | -1.87M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 120.00K | 120.00K | 120.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.77M | -16.22M | 5.95M | 14.11M | 45.70M |
| Cash from Investing | -21.32M | -16.62M | 5.39M | 13.47M | 43.95M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 59.54M | 57.28M | 57.28M | 32.94M | 16.00M |
| Repurchase of Common Stock | -215.00K | -536.00K | -534.00K | -538.00K | -366.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.76M | -387.00K | -387.00K | -387.00K | -387.00K |
| Cash from Financing | 56.56M | 56.36M | 56.36M | 32.02M | 15.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.53M | -11.20M | 8.00K | -21.70M | -11.26M |